Clinical Trial

Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure

Study acronym: ABACUS
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate two treatment strategies in patients with chronic atrial fibrillation and heart failure, who are eligible for atrial fibrillation ablation. Patients will be randomized to either atrial fibrillation ablation or to implantation of a pacemaker with conduction system pacing followed by atrioventricular node ablation. The effect of treatment allocation on total mortality, cardiovascular hospitalization and heart failure hospitalization will be compared.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-04.
Status change: Not Yet Recruiting → Recruiting 2024-12-03
Trial Details
NCT Number NCT06207383
Lead Sponsor University Hospital, Geneva
Collaborators: Swiss National Science Foundation
Conditions Atrial Fibrillation, Persistent, Heart Failure
Enrollment 220 participants
Start Date 2024-10-01
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-06